Chakrapani, Anupam
Valayannopoulos, Vassili
Segarra, Nuria García
Del Toro, Mireia
Donati, Maria Alice
García-Cazorla, Angeles
González, María Julieta
Plisson, Celine
Giordano, Vincenzo
Funding for this research was provided by:
Orphan Europe
Article History
Received: 13 July 2017
Accepted: 11 June 2018
First Online: 20 June 2018
Ethics approval and consent to participate
: The study protocols and amendments were approved by the local independent ethics committees (IECs) and/or institutional review boards. Written informed consent/assent was obtained before data were collected. Cases in which it was not possible to obtain consent (due to death, loss to follow-up) were handled on a case-by-case basis with the relevant IEC. The studies were conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: VV received Principal Investigator fees from Orphan Europe for conducting this study while at Necker-Enfants Malades Hospital. VV is currently an employee of Sanofi Genzyme Corporation, Cambridge, MA. CP, JLM and VG are employees of Orphan Europe.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.